1. Search Result

Search Result

Results for "269730-03-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-101246

    RET Cancer
    RPI-1 is a specific, orally available 2-indolinone Ret tyrosine kinase inhibitor. RPI-1 inhibits proliferation, Ret tyrosine phosphorylation, Ret protein expression, and the activation of PLCgamma, ERKs and AKT in human medullary thyroid carcinoma TT cells. Antitumor activity.